Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tyrosine kinase inhibitor shows potential for leukemias

Jan. 16, 1998

Joint effort on cancer vaccine development

Jan. 16, 1998

Sugen and Asta Medica make progress in Pan-HER collaboration

Jan. 16, 1998

SU-101 advances to phase III for relapsed glioblastoma

Jan. 16, 1998

Gliadel Wafer enters additional phase III study

Jan. 16, 1998

Onyx and Warner-Lambert renew cell cycle regulation agreement

Jan. 16, 1998

Cancer gene therapy technology available for licensing from NIH

Jan. 16, 1998

Novel tumor vaccine technology described by U.S. researchers

Jan. 15, 1998

Pacific receives patent allowance for immune system stimulant

Jan. 15, 1998

New proto-oncogene inhibitor isolated from fungus by Schering-Plough

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...